Fiduciary Alliance’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Sell
68,948
-1,761
-2% -$410K 1.18% 12
2026
Q1
$16.9M Sell
70,709
-3,113
-4% -$725K 1.02% 16
2025
Q4
$15.3M Buy
73,822
+11,198
+18% +$2.21M 1% 17
2025
Q3
$11.6M Sell
62,624
-383
-0.6% -$65.6K 0.78% 26
2025
Q2
$9.62M Sell
63,007
-16,746
-21% -$2.57M 0.72% 32
2025
Q1
$13.2M Buy
79,753
+1,015
+1% +$159K 1.3% 14
2024
Q4
$11.4M Buy
78,738
+5,245
+7% +$813K 1.15% 18
2024
Q3
$11.9M Buy
73,493
+8,978
+14% +$1.43M 1.58% 12
2024
Q2
$9.42M Sell
64,515
-4,302
-6% -$640K 1.53% 16
2024
Q1
$10.9M Sell
68,817
-11,097
-14% -$1.77M 1.92% 11
2023
Q4
$12.5M Sell
79,914
-1,459
-2% -$224K 2.47% 9
2023
Q3
$12.7M Buy
81,373
+882
+1% +$146K 2.93% 9
2023
Q2
$13.3M Buy
80,491
+3,118
+4% +$503K 2.86% 9
2023
Q1
$12M Buy
77,373
+1,598
+2% +$258K 3.01% 8
2022
Q4
$13.4M Buy
+75,775
New +$13.1M 3.46% 5

Other funds holding JNJ

Fiduciary Alliance's JNJ Position: Q2 2026 in Review

Fiduciary Alliance reduced its Johnson & Johnson (JNJ) stake by 2.5% in Q2 2026, selling an estimated $410K and leaving 68,948 shares worth $17.5M. The position accounts for 1.18% of the portfolio, ranked #12.

Fiduciary Alliance first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Fiduciary Alliance held 68,948 shares of Johnson & Johnson worth $17.5M as of Q2 2026.
  • Fiduciary Alliance sold 1,761 Johnson & Johnson shares in Q2 2026, an estimated $410K.
  • Johnson & Johnson made up 1.18% of Fiduciary Alliance's portfolio in Q2 2026, its #12 holding.
  • Fiduciary Alliance first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.